Predictors of Viral Load and Medication Adherence Among HIV-Positive Adults Under Treatment at Felege-Hiwot Comprehensive Specialized Hospital, North-West, Ethiopia

References

• Kim JY, Farmer P, Porter ME. Redefining global health-care delivery. Lancet. 2013;382(9897):1060–1069. doi:10.1016/S0140-6736(13)61047-8
   PubMed Web of Science ®Google Scholar
• Shahzad M, Chen H, Akhtar T, et al. Human immunodeficiency virus: the potential of medicinal plants as antiretroviral therapy. J Med Virol. 2022;94(6):2669–2674. doi:10.1002/jmv.27648
   PubMed Web of Science ®Google Scholar
• Idele P, Gillespie A, Porth T, et al. Epidemiology of HIV and AIDS among adolescents: current status; inequities; and data gaps. J Acquir Immune Defic Syndr. 2014;66:S144–S153. doi:10.1097/QAI.0000000000000176
   PubMed Web of Science ®Google Scholar
• Mohammed H, Assefa N, Mengistie B. Prevalence of extrapulmonary tuberculosis among people living with HIV/AIDS in sub-Saharan Africa: a systemic review and meta-analysis. HIV/AIDS. 2018;10:225.
   Google Scholar
• Kärblane K-G. The Effectiveness of International Organisations in the Fight Against HIV/AIDS. Tartu Ülikool; 2018.
   Google Scholar
• Alemie GA, Gebreselassie F. Common types of tuberculosis and co-infection with HIV at private health institutions in Ethiopia: a cross sectional study. BMC Public Health. 2014;14(1):1–5. doi:10.1186/1471-2458-14-319
   PubMedGoogle Scholar
• Zenebe J. Survival status of undernutrition and its predictors among children who are on antiretroviral therapy in Bahir Dar Town; North West Ethiopia; 2021.
   Google Scholar
• Agegnehu CD, Merid MW, Yenit MK. Incidence and predictors of virological failure among adult HIV patients on first-line antiretroviral therapy in Amhara regional referral hospitals; Ethiopia: a retrospective follow-up study. BMC Infect Dis. 2020;20(1):1–14. doi:10.1186/s12879-020-05177-2
   Web of Science ®Google Scholar
• Mbengue MAS, Chasela C, Onoya D, et al. Clinical predictor score to identify patients at risk of poor viral load suppression at six months on antiretroviral therapy: results from a prospective cohort study in Johannesburg; South Africa. Clin Epidemiol. 2019;11:359. doi:10.2147/CLEP.S197741
   PubMed Web of Science ®Google Scholar
• Rawizza HE, Chaplin B, Meloni ST, et al. Immunologic criteria are poor predictors of virologic outcome: implications for HIV treatment monitoring in resource-limited settings. Clin Infect Dis. 2011;53(12):1283–1290. doi:10.1093/cid/cir729
   PubMed Web of Science ®Google Scholar
• May MT, Gompels M, Delpech V, et al. Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy. AIDS. 2014;28(8):1193. doi:10.1097/QAD.0000000000000243
   PubMed Web of Science ®Google Scholar
• Ayele W, Mulugeta A, Desta A, et al. Treatment outcomes and their determinants in HIV patients on Anti-retroviral treatment program in selected health facilities of Kembata and Hadiya zones; southern nations; nationalities and peoples region; Ethiopia. BMC Public Health. 2015;15(1):1–13. doi:10.1186/s12889-015-2176-5
   PubMedGoogle Scholar
• Lam WY, Fresco P. Medication adherence measures: an overview. Biomed Res Int. 2015;2015:1–12. doi:10.1155/2015/217047
   Web of Science ®Google Scholar
• Angelo AT, Alemayehu DS. Adherence and its associated factors among adult HIV-infected patients on antiretroviral therapy in South Western Ethiopia; 2020. Patient Prefer Adherence. 2021;15:299. doi:10.2147/PPA.S298594
   PubMed Web of Science ®Google Scholar
• Fox MP, Berhanu R, Steegen K, et al. Intensive adherence counselling for HIV‐infected individuals failing second‐line antiretroviral therapy in Johannesburg; South Africa. Trop Med Int Health. 2016;21(9):1131–1137. doi:10.1111/tmi.12741
   PubMed Web of Science ®Google Scholar
• Cochran W. Sampling Techniques. 3rd ed. John Wiley and Sons: New York; 1997.
   Google Scholar
• Velligan DI, Wang M, Diamond P, et al. Relationships among subjective and objective measures of adherence to oral antipsychotic medications. Psychiatr Serv. 2007;58(9):1187–1192. doi:10.1176/ps.2007.58.9.1187
   PubMed Web of Science ®Google Scholar
• Williams A, Low JK, Manias E, et al. Trials and tribulations with electronic medication adherence monitoring in kidney transplantation. Res Social Adm Pharm. 2016;12(5):794–800. doi:10.1016/j.sapharm.2015.10.010
   PubMed Web of Science ®Google Scholar
• Liu L, Strawderman RL, Cowen ME, et al. A flexible two-part random effects model for correlated medical costs. J Health Econ. 2010;29(1):110–123. doi:10.1016/j.jhealeco.2009.11.010
   PubMed Web of Science ®Google Scholar
• Kemp CG, Lipira L, Huh D, et al. HIV stigma and viral load among African-American women receiving treatment for HIV. AIDS. 2019;33(9):1511–1519. doi:10.1097/QAD.0000000000002212
   PubMed Web of Science ®Google Scholar
• Gelb SR, Shapiro R, Thornton W. Predicting medication adherence and employment status following kidney transplant: the relative utility of traditional and everyday cognitive approaches. Neuropsychology. 2010;24(4):514. doi:10.1037/a0018670
   PubMed Web of Science ®Google Scholar
• Reid R, Dale SK. Moderating effects of social support on the relationship between substance use disorders and HIV viral load and medication adherence among Black women living with HIV in the United States. AIDS Care. 2021;2021:1–10.
   Google Scholar
• Hinkin CH, Hardy DJ, Mason KI, et al. Medication adherence in HIV-infected adults: effect of patient age; cognitive status; and substance abuse. AIDS. 2004;18(Suppl 1):S19. doi:10.1097/00002030-200401001-00004
   PubMed Web of Science ®Google Scholar
• Malta M, Strathdee SA, Magnanini MMF, et al. Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review. Addiction. 2008;103(8):1242–1257. doi:10.1111/j.1360-0443.2008.02269.x
   PubMed Web of Science ®Google Scholar
• Teter CJ, Falone AE, Bakaian AM, et al. Medication adherence and attitudes in patients with bipolar disorder and current versus past substance use disorder. Psychiatry Res. 2011;190(2–3):253–258. doi:10.1016/j.psychres.2011.05.042
   PubMed Web of Science ®Google Scholar
• Shoko C, Chikobvu D. A superiority of viral load over CD4 cell count when predicting mortality in HIV patients on therapy. BMC Infect Dis. 2019;19(1):1–10. doi:10.1186/s12879-019-3781-1
   PubMedGoogle Scholar
• Swindells S, Jiang H, Mukherjee AL, et al. Lower CD4 cell count and higher virus load; but not antiretroviral drug resistance; are associated with AIDS-defining events and mortality: an ACTG Longitudinal Linked Randomized Trials (ALLRT) analysis. HIV Clin Trials. 2011;12(2):79–88. doi:10.1310/hct1202-79
   PubMed Web of Science ®Google Scholar
• Desta AA, Wubayehu Woldearegay T, Berhe AA, et al. Immunological recovery; failure and factors associated with CD-4 T-cells progression over time; among adolescents and adults living with HIV on Antiretroviral Therapy in Northern Ethiopia: a retrospective cross sectional study. PLoS One. 2019;14(12):e0226293. doi:10.1371/journal.pone.0226293
   PubMed Web of Science ®Google Scholar
• Abrogoua DP, Kablan BJ, Kamenan BA, et al. Assessment of the impact of adherence and other predictors during HAART on various CD4 cell responses in resource-limited settings. Patient Prefer Adherence. 2012; 6:227.
   PubMed Web of Science ®Google Scholar
• Lima VD, Harrigan R, Murray M, et al. Differential impact of adherence on long-term treatment response among naive HIV-infected individuals. AIDS. 2008;22(17):2371–2380. doi:10.1097/QAD.0b013e328315cdd3
   PubMed Web of Science ®Google Scholar